Calla positive acute lymphoblastic leukemia after etoposide-based therapy for Ewing's sarcoma.

[1]  N R Schneider,et al.  Secondary acute myeloid leukemia in children with acute lymphoblastic leukemia treated with etoposide. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  H. B. Marsden,et al.  Epipodophyllotoxins, alkylating agents, and radiation and risk of secondary leukaemia after childhood cancer. , 1992, BMJ.

[3]  J. Rowley,et al.  Identification of a gene, MLL, that spans the breakpoint in 11q23 translocations associated with human leukemias. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[4]  J. Hainsworth,et al.  Therapy-related acute nonlymphocytic leukemia with monocytic features and rearrangement of chromosome 11q. , 1989, Annals of internal medicine.

[5]  M. Leppert,et al.  Localization of an ataxia-telangiectasia gene to chromosome 11q22–23 , 1988, Nature.

[6]  L. Buluwela,et al.  Physical linkage of three CD3 genes on human chromosome 11. , 1987, The EMBO journal.

[7]  R. Larson,et al.  Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no. 5 and 7. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  O. Oberlin,et al.  Second malignant neoplasms in children: an update from the Late Effects Study Group. , 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  M. Greene,et al.  Subsequent cancer in patients with Ewing's sarcoma. , 1979, Cancer treatment reports.

[10]  L. Strong,et al.  Risk of radiation-related subsequent malignant tumors in survivors of Ewing's sarcoma. , 1979, Journal of the National Cancer Institute.